Detalhe da pesquisa
1.
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial.
Lancet Oncol
; 24(3): 273-285, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36858723
2.
Nodal positivity and systemic therapy among patients with clinical T1-T2N0 human epidermal growth factor receptor-positive breast cancer: Results from two international cohorts.
Cancer
; 129(12): 1836-1845, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36951169
3.
Individualizing Curative-Intent Therapy in HER2-Positive Early-Stage Breast Cancer.
Curr Treat Options Oncol
; 24(5): 479-495, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36995527
4.
Prospective Study Testing a Simplified Paclitaxel Premedication Regimen in Patients with Early Breast Cancer.
Oncologist
; 26(11): 927-933, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34472667
5.
Breast Cancer Treatment: A Review.
JAMA
; 321(3): 288-300, 2019 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30667505
6.
Fertility Preservation in Patients With Breast Cancer: Necessity, Methods, and Safety.
J Natl Compr Canc Netw
; 14(3): 355-63, 2016 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26957619
7.
Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors.
Breast Cancer Res Treat
; 154(2): 359-67, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26420402
8.
The evolving understanding of small HER2-positive breast cancers: matching management to outcomes.
Future Oncol
; 11(24): 3261-71, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26634944
9.
Breast Cancer Treatment.
JAMA
; 321(3): 316, 2019 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-30667503
10.
Axillary Nodal Response to Neoadjuvant T-DM1 Combined with Pertuzumab in a Prospective Phase II Multi-Institution Clinical Trial.
J Am Coll Surg
; 238(3): 303-311, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38047578
11.
Prognosis and treatment outcomes for patients with stage IA triple-negative breast cancer.
NPJ Breast Cancer
; 10(1): 26, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38575691
12.
HER2 heterogeneity and treatment response-associated profiles in HER2-positive breast cancer in the NCT02326974 clinical trial.
J Clin Invest
; 134(7)2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38300710
13.
Assessment of the HER2DX Assay in Patients With ERBB2-Positive Breast Cancer Treated With Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab.
JAMA Oncol
; 9(6): 835-840, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37103927
14.
Impact of Neoadjuvant Paclitaxel/Trastuzumab/Pertuzumab on Breast Tumor Downsizing for Patients with HER2+ Breast Cancer: Single-Arm Prospective Clinical Trial.
J Am Coll Surg
; 237(2): 247-256, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37194964
15.
Genomics of ERBB2-Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus Trastuzumab.
JCO Precis Oncol
; 7: e2300076, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37364233
16.
Assessment of a Genomic Assay in Patients With ERBB2-Positive Breast Cancer Following Neoadjuvant Trastuzumab-Based Chemotherapy With or Without Pertuzumab.
JAMA Oncol
; 9(6): 841-846, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37103916
17.
Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer.
J Immunother Cancer
; 10(10)2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36252998
18.
Somatic and Germline Genomic Alterations in Very Young Women with Breast Cancer.
Clin Cancer Res
; 28(11): 2339-2348, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35101884
19.
A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer.
NPJ Breast Cancer
; 8(1): 63, 2022 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35538105
20.
The Immunology of Hormone Receptor Positive Breast Cancer.
Front Immunol
; 12: 674192, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34135901